These cross sectional data showed a significant linear association (p <0 001) between consumption of coffee in men and plasma cholesterol and low density lipoprotein cholesterol concentrations. Men who drank five cups of coffee or more had plasma cholesterol concentrations about 0 5 mmol/l (20 mg/100 ml) higher than non-drinkers after controlling for age, ethnicity, body mass, education, season of year, smoking, tea drinking, and dietary intake of fat and carbohydrates. In women adjusted mean plasma cholesterol concentration was 0-34 mmol/l (13 mg/100 ml) higher in coffee drinkers grouped together (p <0 01). The test for a linear trend was not significant. The association in both sexes was largely with the low density lipoprotein cholesterol fraction. High density lipoprotein cholesterol concentrations were somewhat increased in women who drank coffee (p <0 01 for a linear trend) but not in men. Tea drinking was not associated with unadjusted plasma cholesterol concentrations in either sex. Male tea drinkers, but not female, had slightly higher adjusted plasma cholesterol concentrations than non-drinkers (015 mmol/l (6 mg/100 ml), p=004). No dose response relation was evident.
Introduction
Recently the Troms0 heart study reported a strong linear association between consumption of coffee and serum cholesterol concentrations in a large population sample of men and women. Intake of nutrients was not controlled in the analysis. ' The same investigators subsequently supported their cross sectional findings with a small crossover trial using black boiled coffee.' We studied this relation in a sample of 1596 residents of Jerusalem for whom detailed dietary data as well as information on intake of beverages were available. The Israeli and Norwegian BRITISH MEDICAL JOURNAL VOLUME 291 14 SEPTEMBER 1985 ded details of additives (mainly milk and sugar) but not of methods of brewing or strength of the beverage. We coded the number of cups of coffee consumed in the 24 hour period of recall according to whether the coffee was drunk with or without added milk. Our primary question related to the association of coffee drinking with plasma cholesterol concentrations, but the issue of whether tea showed the same association as coffee was also of interest. Coffee and tea drinking were inversely correlated in our study population (r= -0-4). Each beverage was controlled for when the independent effects of the other were assessed. We adjusted for two nutrient variables-namely, saturated fatty acids and sugar-each of which was expressed as a percentage of 24 (25) 242 (24) 38 (12) 38 (15) 54 (21) 37 (21) 167 (17) 3 71 (23) 41 (16) 34 (13) 25 (14) 171 (17) 22 (7) 18 (7) 38 (15) 20 (11) 98 (10) 4 37 (12) 28 (11) 16 (6) 18 (10) 99 (10) 18 (6) 12 (5) 28 (11) 21 (12) 79 (8) 5+ 57 (18) 35 (13) 14 (5) 13 (7) 119 (12) 10 (3) 7 (3) 35 (14) 10 (6) 62 (6) Total No of men  311  261  256  179  1007  311  261  256  179  1007  Women  0 5 (3) 16 (13) 36 (24) 15 (13) 72 (12) 119 (60) 68 (54) 46 (31) 34 (29) 267 (45) 1 25 (13) 24 (19) 38 (26) 36 (31) 123 (21) 47 (24) 31 (24) 26 (17) 33 (28) 137 (23) 2 42 (21) 20 (16) 33 (22) 33 (28) 128 (22) 16 (8) 11 (9) 33 (22) 27 (23) 87 (15) 3 46 (23) 29 (23) 20 (13) 16 (14) 111 (19) 8 (4) 4 (3) 19 (13) 12 (10) 43 (7) 4 35 (18) 18 (14) 13 (9) 14 (12) 80 (14) 3 (2) 6 (5) 11 (7) 7 (6) 27 (5) 5 + 44 (22) 20 (16) 9 (6) 2 (2) 75 (13) 4 (2) 7 (6) 14 (9) 3 (3) 28 (5) 
Discussion
In our multiethnic population there appeared to be a substantial association of plasma cholesterol concentration with the reported intake of coffee over 24 hours. The evidence was stronger in men than in women. The findings were generally positive in the ethnic groups in both sexes. Apparent ethnic differences in the strength of the association require confirmation. The ethnic groups in Israel differ in their dietary intake and probably in their coffee brewing habits. A linear association was maintained in men after control for several covariates, including nutrients that reflect additives to the beverages as well as dietary patterns. In the smaller sample of women, coffee drinkers had higher adjusted mean plasma cholesterol concentrations than nondrinkers, although a test for a linear trend was not significant except when those born in Israel were excluded. The association in both sexes was mostly with the low density lipoprotein fraction of plasma cholesterol. Adjustment for potential confounders had a moderate overall effect on the magnitude and standard error of the regression coefficients for cholesterol and low density lipoprotein cholesterol. Adjustment for several variables (season, intake of fat, and particularly ethnicity) tended to weaken the association; this was partly offset by other variables (age, intake of tea, body mass). The relation with high density lipoprotein cholesterol concentrations was weakly inverse in men and moderately positive in women (limited mainly to women born in Asia and north Africa). The ratio of high density lipoprotein cholesterol to total cholesterol was lower in male coffee drinkers but not in female. In the larger Tromso study a linear association with cholesterol concentrations was evident in both sexes, whereas findings for high density lipoprotein cholesterol concentrations on adjustment were inconsistent.' In the Evans county study an association of low density lipoprotein cholesterol concentrations with intake of coffee was apparent only in cigarette smokers.19 In our study there was no evidence for an interaction between smoking and coffee (data not shown).
Our data are lacking in that we did not collect information about the methods of brewing coffee or about the strength of the coffee. Our impression is that consumption of decaffeinated coffee was rare and use of percolators was unusual in Israel during the period of the study. Most coffee was probably prepared as instant coffee, ground coffee to which boiling water was added, or boiled ground coffee. According to national food balance sheets, coffee extract was processed from over 40% of imports of coffee beans.' A standard serving of instant coffee in Israel comprises 1-8 To what extent does 24 hour dietary recall reflect usual coffee consumption ? This question would be particularly relevant if the effect of coffee on the increase in cholesterol concentrations (if causal) were non-acute. Misclassification of intake of coffee would then probably tend to underestimate the true association. The Troms0 trial suggests that the response is incremental over at least four weeks.2 A small study in Jerusalem, however, showed a stronger association with intake of coffee reported for the previous day than with usual coffee consumption.20 A subsample (numbering 606) of our population analysed in the present report was re-examined after a median of 27 months. The correlation of intake of coffee in the two 24 hour periods of recall was over 0-6 in both men and women, while the corresponding correlations for tea were 0 5 and 0-6. The correlations for saturated fatty acids and sugar were much lower. Thus coffee drinking in our population as ascertained by 24 hour recall was moderately consistent over long periods and almost certainly more so over several weeks.
Evidence in our study for an association of tea drinking with total plasma cholesterol concentrations was equivocal in men and absent in women. After adjustment for coffee drinking and other covariates a weak relation emerged in men. This could be a chance finding. There was no evidence for a dose response. The lack of a positive relation was noted in several studies.20-2' 29 30 One report, however, showed a linear association (with caffeine estimated from intake of tea) in women, though not in men.25 Few of the studies controlled for the potential confounding effect of coffee.20 25 The role of caffeine, present in both coffee and tea, in raising cholesterol concentrations has been questioned. On the basis of a trial that showed an increase in serum cholesterol concentrations after subjects used decaffeinated coffee for 14 days,32 and the apparent lack of a positive association with intake of tea in several studies, it was suggested that constituents in coffee other than caffeine may play a part in raising cholesterol concentrations.1 2 Others argue that caffeine is the component responsible.25
The magnitude of the association of coffee and cholesterol was similar in our study and in Troms0, where about 80% of the coffee consumed was boiled ground coffee taken strong and black and where 60% of men and 50% of women drank five or more cups a day. The amounts consumed in Jerusalem were much smaller. Information from the national food balance sheets of Norway and Israel is consistent with these data on coffee consumption.6 The supply of ground coffee was much larger in Norway than in Israel (19-0 v 4-3 g/day) and supply of coffee extract about equal (0-7 v 0-8 g/day), while that of tea was larger in Israel (0-6 v 2-7 g/day). Thus the potential effect of coffee drinking on serum or plasma cholesterol concentrations in the population, assuming causality, is lower in Israel than in Scandinavia, although still quite substantial (about 0-13-0-26 mmol/l (5-10 mg/100 ml) as estimated from our study).
Further trials are needed to establish whether the relation is causal and to determine the responsible constituent(s SHORT REPORTS Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride Cutaneous leishmaniasis, a protozoal disease, continues to present important therapeutic problems and, though usually self limiting, can cause considerable morbidity. It may result in severe disfigurement. Recurrent cutaneous leishmaniasis, or leishmaniasis recidivans, is a rare form of the disease caused by Leishmania tropica (formerly L tropica minor), and occurs on or near healed leishmaniasis scars months to years after total or partial resolution of the acute lesion.
Currently, no satisfactory treatment exists for either condition.
The available drugs-the pentavalent antimonials, the diamidines, amphotericin B, and emetine hydrochloride-are all unpredictable and unsatisfactory and occasionally cause severe toxicity.' Few studies have dealt with topical treatment. Recently, local treatment with chlorpromnazine ointment was successfully used against diffuse cutaneous leishmaniasis. Topical treatment with imidazole derivatives, however, was ineffective in cutaneous leishmaniasis in both experimental animals and man.3 During the past few years an effective topical treatment of cutaneous leishmaniasis has been developed. BALB/c mice with early and advanced infection with L major LRC-L137 were treated with an ointment containing 15% paromomycin sulphate and 12% methylbenzethonium chloride in white soft paraffin (UK patent number GB 2117237A). All the mice were completely cured of cutaneous disease after application of the ointment twice daily for six to 10 days.4 Treatment of lesions in the base of the tail eliminated only the parasites in those lesions; the internal organs and other, untreated lesions remained heavily infected.
Case reports
In a preliminary clinical study two patients with recurrent cutaneous leishmaniasis were treated with an ointment comprising 15% paromomycin sulphate and 1% methylbenzethonium chloride (supplied by Teva Pharmaceutical Industries Ltd, Jerusalem) twice daily for 80 days. Case 1-The patient was a 54 year old woman with a 50 year history of leishmaniasis who had immigrated from Iraq in 1951. She had three crusted, ulcerated lesions 1-3 cm in diameter, one on the nose and two on her left cheek ( figure (a) ). Before attending our clinic she had been treated unsuccessfully with emetine hydrochloride, with severe toxic side effects.
Case 2 The patient was a 58 year old man with recurrent cutaneous leishmaniasis, which had first developed 47 years previously, also in Iraq. He had been unsuccessfully treated with various drugs including emetine
